TABULA RASA HEALTHCARE INC (TRHC) Fundamental Analysis & Valuation

NASDAQ:TRHC • US8733791011

Current stock price

10.5 USD
+0.09 (+0.86%)
Last:

This TRHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. TRHC Profitability Analysis

1.1 Basic Checks

  • TRHC had negative earnings in the past year.
  • In the past year TRHC has reported a negative cash flow from operations.
TRHC Yearly Net Income VS EBIT VS OCF VS FCFTRHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 0 -50M -100M

1.2 Ratios

  • TRHC has a Return On Assets (-26.82%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -26.82%
ROE N/A
ROIC N/A
ROA(3y)-23.32%
ROA(5y)-18.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TRHC Yearly ROA, ROE, ROICTRHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 100 -100 200

1.3 Margins

  • TRHC has a Gross Margin of 23.61%. This is amonst the worse of the industry: TRHC underperforms 83.72% of its industry peers.
  • In the last couple of years the Gross Margin of TRHC has declined.
  • TRHC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.95%
GM growth 5Y-5.61%
TRHC Yearly Profit, Operating, Gross MarginsTRHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 20 -20 -40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. TRHC Health Analysis

2.1 Basic Checks

  • TRHC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for TRHC has been increased compared to 1 year ago.
  • The debt/assets ratio for TRHC is higher compared to a year ago.
TRHC Yearly Shares OutstandingTRHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M
TRHC Yearly Total Debt VS Total AssetsTRHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M 400M 500M

2.2 Solvency

  • TRHC has an Altman-Z score of -0.66. This is a bad value and indicates that TRHC is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -0.66, TRHC perfoms like the industry average, outperforming 44.19% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.66
ROIC/WACCN/A
WACC8.36%
TRHC Yearly LT Debt VS Equity VS FCFTRHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 100M 200M 300M

2.3 Liquidity

  • TRHC has a Current Ratio of 1.57. This is a normal value and indicates that TRHC is financially healthy and should not expect problems in meeting its short term obligations.
  • TRHC has a Current ratio of 1.57. This is in the lower half of the industry: TRHC underperforms 60.47% of its industry peers.
  • A Quick Ratio of 1.47 indicates that TRHC should not have too much problems paying its short term obligations.
  • TRHC's Quick ratio of 1.47 is on the low side compared to the rest of the industry. TRHC is outperformed by 60.47% of its industry peers.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 1.47
TRHC Yearly Current Assets VS Current LiabilitesTRHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. TRHC Growth Analysis

3.1 Past

  • TRHC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 50.00%, which is quite impressive.
  • Looking at the last year, TRHC shows a very strong growth in Revenue. The Revenue has grown by 22.28%.
  • TRHC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.54% yearly.
EPS 1Y (TTM)50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%112%
Revenue 1Y (TTM)22.28%
Revenue growth 3Y1.71%
Revenue growth 5Y17.54%
Sales Q2Q%24.02%

3.2 Future

  • TRHC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.23% yearly.
  • TRHC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.28% yearly.
EPS Next Y94.12%
EPS Next 2Y52.76%
EPS Next 3Y34.23%
EPS Next 5YN/A
Revenue Next Year21.88%
Revenue Next 2Y18.38%
Revenue Next 3Y17.28%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
TRHC Yearly Revenue VS EstimatesTRHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
TRHC Yearly EPS VS EstimatesTRHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1 -2

More info and screens

Find the best growth stocksShow best growing peers

2

4. TRHC Valuation Analysis

4.1 Price/Earnings Ratio

  • TRHC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • TRHC is valuated quite expensively with a Price/Forward Earnings ratio of 40.37.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of TRHC indicates a somewhat cheap valuation: TRHC is cheaper than 74.42% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of TRHC to the average of the S&P500 Index (22.79), we can say TRHC is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 40.37
TRHC Price Earnings VS Forward Price EarningsTRHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TRHC Per share dataTRHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

  • TRHC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • TRHC's earnings are expected to grow with 34.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y52.76%
EPS Next 3Y34.23%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TRHC Dividend Analysis

5.1 Amount

  • TRHC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

TRHC Fundamentals: All Metrics, Ratios and Statistics

TABULA RASA HEALTHCARE INC

NASDAQ:TRHC (11/2/2023, 8:12:48 PM)

10.5

+0.09 (+0.86%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-07
Earnings (Next)03-04
Inst Owners0%
Inst Owner Change0%
Ins Owners47.24%
Ins Owner Change0%
Market Cap284.02M
Revenue(TTM)338.12M
Net Income(TTM)-95.46M
Analysts48.89
Price Target10.71 (2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)105.51%
Min EPS beat(2)85.99%
Max EPS beat(2)125.03%
EPS beat(4)3
Avg EPS beat(4)27.01%
Min EPS beat(4)-127.59%
Max EPS beat(4)125.03%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.19%
Min Revenue beat(2)-0.68%
Max Revenue beat(2)3.05%
Revenue beat(4)3
Avg Revenue beat(4)1.2%
Min Revenue beat(4)-0.68%
Max Revenue beat(4)3.05%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)25.37%
EPS NQ rev (1m)0%
EPS NQ rev (3m)77.78%
EPS NY rev (1m)0%
EPS NY rev (3m)85.48%
Revenue NQ rev (1m)0.41%
Revenue NQ rev (3m)0.53%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.25%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 40.37
P/S 0.84
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.3
EYN/A
EPS(NY)0.26
Fwd EY2.48%
FCF(TTM)-0.89
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS12.5
BVpS-2.89
TBVpS-9.67
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -26.82%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.61%
FCFM N/A
ROA(3y)-23.32%
ROA(5y)-18.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.95%
GM growth 5Y-5.61%
F-Score2
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 77.37%
Cap/Sales 5.59%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.57
Quick Ratio 1.47
Altman-Z -0.66
F-Score2
WACC8.36%
ROIC/WACCN/A
Cap/Depr(3y)72.04%
Cap/Depr(5y)69.33%
Cap/Sales(3y)10.17%
Cap/Sales(5y)8.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%112%
EPS Next Y94.12%
EPS Next 2Y52.76%
EPS Next 3Y34.23%
EPS Next 5YN/A
Revenue 1Y (TTM)22.28%
Revenue growth 3Y1.71%
Revenue growth 5Y17.54%
Sales Q2Q%24.02%
Revenue Next Year21.88%
Revenue Next 2Y18.38%
Revenue Next 3Y17.28%
Revenue Next 5YN/A
EBIT growth 1Y-16.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year137.28%
EBIT Next 3Y39.09%
EBIT Next 5YN/A
FCF growth 1Y0.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-320.17%
OCF growth 3YN/A
OCF growth 5Y-16.67%

TABULA RASA HEALTHCARE INC / TRHC Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for TABULA RASA HEALTHCARE INC?

ChartMill assigns a fundamental rating of 2 / 10 to TRHC.


Can you provide the valuation status for TABULA RASA HEALTHCARE INC?

ChartMill assigns a valuation rating of 2 / 10 to TABULA RASA HEALTHCARE INC (TRHC). This can be considered as Overvalued.


How profitable is TABULA RASA HEALTHCARE INC (TRHC) stock?

TABULA RASA HEALTHCARE INC (TRHC) has a profitability rating of 1 / 10.


How financially healthy is TABULA RASA HEALTHCARE INC?

The financial health rating of TABULA RASA HEALTHCARE INC (TRHC) is 1 / 10.


What is the earnings growth outlook for TABULA RASA HEALTHCARE INC?

The Earnings per Share (EPS) of TABULA RASA HEALTHCARE INC (TRHC) is expected to grow by 94.12% in the next year.